Sen. Markwayne Mullin Sells Zoetis Inc. (NYSE:ZTS) Stock

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Zoetis Inc. NYSE: ZTS. In a filing disclosed on May 12th, the Senator disclosed that they had sold between $15,001 and $50,000 in Zoetis stock on April 8th.

Senator Markwayne Mullin also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Texas Instruments NASDAQ: TXN on 4/8/2025.
• Sold $15,001 - $50,000 in shares of CSX NASDAQ: CSX on 4/8/2025.
• Sold $50,001 - $100,000 in shares of Lam Research NASDAQ: LRCX on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Chevron NYSE: CVX on 4/8/2025.
• Sold $50,001 - $100,000 in shares of Thermo Fisher Scientific NYSE: TMO on 4/8/2025.
• Sold $15,001 - $50,000 in shares of ConocoPhillips NYSE: COP on 4/8/2025.
• Sold $50,001 - $100,000 in shares of Applied Materials NASDAQ: AMAT on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 4/8/2025.
• Sold $50,001 - $100,000 in shares of Valero Energy NYSE: VLO on 4/8/2025.
• Purchased $15,001 - $50,000 in shares of Capital One Financial NYSE: COF on 3/19/2025.

Zoetis Trading Up 3.4%

Zoetis stock traded up $5.34 during mid-day trading on Thursday, hitting $160.26. 3,536,194 shares of the stock were exchanged, compared to its average volume of 2,511,156. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. The firm's fifty day simple moving average is $156.72 and its two-hundred day simple moving average is $165.71. Zoetis Inc. has a 12 month low of $139.70 and a 12 month high of $200.33. The stock has a market capitalization of $71.35 billion, a price-to-earnings ratio of 29.30, a PEG ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the previous year, the business posted $1.38 EPS. Zoetis's revenue for the quarter was up 1.4% compared to the same quarter last year. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Institutional Investors Weigh In On Zoetis

Hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank bought a new position in Zoetis in the 4th quarter worth $824,321,000. Nuveen LLC purchased a new stake in Zoetis in the first quarter worth approximately $616,375,000. Wellington Management Group LLP boosted its position in Zoetis by 78.5% in the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock worth $1,133,755,000 after purchasing an additional 3,059,255 shares during the last quarter. Sarasin & Partners LLP bought a new stake in shares of Zoetis during the 1st quarter valued at $339,111,000. Finally, Mackenzie Financial Corp raised its stake in Zoetis by 4,158.3% during the 1st quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company's stock worth $300,481,000 after acquiring an additional 1,782,110 shares during the period. Institutional investors own 92.80% of the company's stock.

Insider Transactions at Zoetis

In related news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the transaction, the executive vice president now directly owns 15,781 shares of the company's stock, valued at approximately $2,682,770. The trade was a 2.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total transaction of $201,029.40. Following the completion of the sale, the director now directly owns 11,245 shares in the company, valued at $1,868,244.30. This trade represents a 9.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.16% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ZTS. Piper Sandler raised their price target on shares of Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research report on Monday. StockNews.com upgraded Zoetis from a "hold" rating to a "buy" rating in a report on Friday, March 7th. UBS Group decreased their target price on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Stifel Nicolaus cut their price target on shares of Zoetis from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, Morgan Stanley reduced their target price on shares of Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $212.75.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father's plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.